Bursa Announcements
Stock Name / Code :
DPHARMA ( 7148 )
Year :
2026
2025
2024
2023
2022
Archives
Select Date Range :
Categories :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Filter
Reset
Wednesday - 19 Aug 2026
DPHARMA - Notice of Book Closure
Tuesday - 18 Aug 2026
First Interim Dividend
Quarterly rpt on consolidated results for the financial period ended 30 Jun 2026
OTHERS
Duopharma Biotech maintains healthy profit growth in H1FY2026
Tuesday - 11 Aug 2026
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Friday - 7 Aug 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Friday - 31 Jul 2026
OTHERS
CONTRACTS FOR THE SUPPLY BY DUOPHARMA (M) SENDIRIAN BERHAD, DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. AND DUOPHARMA HAPI SDN. BHD. (ALL WHOLLY-OWNED SUBSIDIARY COMPANIES OF DUOPHARMA BIOTECH BERHAD), THROUGH PHARMANIAGA LOGISTICS SDN. BHD. OF PHARMACEUTICAL AND/OR NON-PHARMACEUTICAL PRODUCTS FOR THE MINISTRY OF HEALTH OF MALAYSIA UNDER THE APPROVED PRODUCTS PURCHASE LIST (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
Tuesday - 28 Jul 2026
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Monday - 20 Jul 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Thursday - 9 Jul 2026
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Tuesday - 9 Jun 2026
OTHERS
ACCEPTANCE OF TENDER OFFER (HEREINAFTER REFERRED TO AS THE "LETTER OF AWARD" OR "LOA") FOR THE SUPPLY OF RECOMBINANT HUMAN INSULIN 100 IU/ML PENFILL/REFILL AS A PACKAGE (HEREINAFTER REFERRED TO AS THE "PRODUCTS") BY DUOPHARMA (M) SENDIRIAN BERHAD (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) TO THE MINISTRY OF HEALTH'S FACILITIES FOR THREE YEARS (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
MATERIAL LITIGATION
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Friday - 22 May 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Thursday - 21 May 2026
OTHERS
Duopharma Biotech Contributes to National Pharmaceutical Self-Reliance Through Manufacturing Capacity and Portfolio Growth
GENERAL MEETINGS: Outcome of Meeting
«
1
2
3
4
5
6
7
8
9
10
»